Next-generation Sequencing Market, Share and Forecast upto 2024
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate, owing to its rising adoption in scientific applications as it enables scanning of targeted genomes or whole genomes in lesser time. Moreover, decrease in cost of sequencing has also extended the procedure of next generation sequencing in various clinical applications. The technique has a variety of usages in diverse clinical applications such as inherited genetic disorders, cancer, identification of infectious diseases and HLA typing. For example, next-generation sequencing has been in use for tracing tuberculosis outbreaks and hospital acquired infections. These factors are projected to propel growth of the next-generation sequencing market over the forecast period (2016-2024).
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate, owing to its rising adoption in scientific applications as it enables scanning of targeted genomes or whole genomes in lesser time. Moreover, decrease in cost of sequencing has also extended the procedure of next generation sequencing in various clinical applications. The technique has a variety of usages in diverse clinical applications such as inherited genetic disorders, cancer, identification of infectious diseases and HLA typing. For example, next-generation sequencing has been in use for tracing tuberculosis outbreaks and hospital acquired infections. These factors are projected to propel growth of the next-generation sequencing market over the forecast period (2016-2024).
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Next</strong>-<strong>generation</strong> <strong>Sequencing</strong> <strong>Market</strong> -<br />
GLOBAL INDUSTRY INSIGHTS, TRENDS,<br />
OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016-<br />
<strong>2024</strong><br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Next</strong>-<strong>generation</strong> <strong>Sequencing</strong> <strong>Market</strong> – Overview<br />
<strong>Next</strong>-<strong>generation</strong> sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina<br />
(Solexa) sequencing, Roche 454 sequencing, <strong>and</strong> Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. <strong>Next</strong>-<strong>generation</strong><br />
sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, <strong>and</strong> reduced sequencing cost.<br />
<strong>Next</strong>-<strong>generation</strong> sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS<br />
technology is developing at a rapid rate, owing to its rising adoption in scientific applications as it enables scanning of targeted<br />
genomes or whole genomes in lesser time. Moreover, decrease in cost of sequencing has also extended the procedure of next<br />
<strong>generation</strong> sequencing in various clinical applications. The technique has a variety of usages in diverse clinical applications such as<br />
inherited genetic disorders, cancer, identification of infectious diseases <strong>and</strong> HLA typing. For example, next-<strong>generation</strong> sequencing<br />
has been in use for tracing tuberculosis outbreaks <strong>and</strong> hospital acquired infections. These factors are projected to propel growth of<br />
the next-<strong>generation</strong> sequencing market over the forecast period (2016-<strong>2024</strong>).<br />
According to an article published in the magazine Scientific American, whole genome testing might not give accurate results all the<br />
time. A low risk disease might take a shape <strong>and</strong> affect the person in his lifetime. However, gene sequencing is helpful in predicting<br />
diseases <strong>and</strong> in most cases, preventing them. In the era of increased health awareness <strong>and</strong> advanced technologies, people around the<br />
world are embracing the early detection techniques so that they can take care of the diseases such as cancer from an early stage.<br />
<strong>Next</strong> <strong>generation</strong> sequencing is primarily used to predict the diseases which are hereditary in nature.<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Next</strong>-<strong>generation</strong> <strong>Sequencing</strong> <strong>Market</strong> Taxonomy:<br />
On the basis of technology, the global is classified into:<br />
<strong>Sequencing</strong> By Synthesis (SBS)<br />
<strong>Sequencing</strong> By Ligation (SBL)<br />
ION Semiconductor <strong>Sequencing</strong><br />
Single-Molecule Real-Time <strong>Sequencing</strong> (SMRT)<br />
Pyrosequencing<br />
Genomics<br />
Whole Genome <strong>Sequencing</strong><br />
Exome <strong>Sequencing</strong><br />
De Novo <strong>Sequencing</strong><br />
Targeted <strong>Sequencing</strong><br />
Transcriptomics<br />
Total RNA <strong>and</strong> mRNA <strong>Sequencing</strong><br />
Targeted RNA <strong>Sequencing</strong><br />
Request report sample for more professional <strong>and</strong> technical insights:<br />
https://www.coherentmarketinsights.com/insight/request-sample/158<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Next</strong>-<strong>generation</strong> <strong>Sequencing</strong> <strong>Market</strong> Taxonomy:<br />
Small RNA <strong>and</strong> Non coding RNA SEQUENCIMG<br />
Epigenomics<br />
Other<br />
Methylation <strong>Sequencing</strong><br />
CHIP <strong>Sequencing</strong><br />
Ribosome Profiling<br />
On the basis of application, the global is classified into:<br />
Diagnostics<br />
Drug Discovery<br />
Agriculture & Animal Research<br />
Personalized Medicine<br />
Biomarker Discovery<br />
Others<br />
On the basis of end user, the global is classified into:<br />
Research Centers & Academic/Government Institutes<br />
Hospitals & Clinics<br />
Pharmaceutical & Biotechnology Companies<br />
Others<br />
Click here to know more about this report:<br />
https://www.coherentmarketinsights.com/ongoing-insight/next-<strong>generation</strong>-sequencing-market-158<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Next</strong>-<strong>generation</strong> <strong>Sequencing</strong> <strong>Market</strong>: Key Players<br />
Major players involved in the next-<strong>generation</strong> sequencing market include:<br />
●<br />
Life Sciences Corporation (Roche Holding Ag)<br />
●<br />
Agilent Technologies<br />
●<br />
Life Technologies Corporation<br />
●<br />
Perkin Elmer<br />
●<br />
Genomatix Software Gmbh<br />
●<br />
Illumina, Inc.<br />
●<br />
Genomatix Software Gmbh<br />
●<br />
Macrogen, Inc.<br />
●<br />
Oxford Nanopore Technologies,Ltd.<br />
●<br />
Gatc Biotech Ag<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence <strong>and</strong> consulting<br />
organization focused on assisting its plethora of clients achieve transformational<br />
growth by helping them make critical business decisions. We are headquartered in<br />
India, with an office at the global financial capital in the U.S. Our client base<br />
includes players from across all business verticals in over 150 countries worldwide.<br />
We are uniquely positioned to help businesses around the globe deliver practical<br />
<strong>and</strong> lasting results through various recommendations about operational<br />
improvements, technologies, emerging market trends <strong>and</strong> new working methods.<br />
We offer both customized <strong>and</strong> syndicated market research reports that help our<br />
clients create visionary growth plans to provide traction to their business. We<br />
meticulously study emerging trends across various industries at both the global<br />
<strong>and</strong> regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
Industries we cater<br />
SECTOR COVERAGE<br />
Healthcare<br />
BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality <strong>and</strong> Fine<br />
Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic<br />
Ingredients<br />
Polymers &<br />
Resins<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
Insights Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEAR<br />
CH<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts <strong>and</strong> Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, <strong>and</strong> food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed <strong>and</strong> highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets <strong>and</strong> also key inputs to help them tap into emerging markets <strong>and</strong> exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
© Coherent market Insights. All Rights Reserved
Change language